{"gene":"KLRD1","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1995,"finding":"CD94 is a type II membrane glycoprotein encoded by a unique gene of the C-type lectin superfamily, located on human chromosome 12, and has an essentially absent cytoplasmic domain, implying association with other receptors is necessary for its function.","method":"Molecular cloning, sequence analysis, chromosomal mapping","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — original molecular characterization with cloning, sequence, and chromosomal mapping","pmids":["7589107"],"is_preprint":false},{"year":1996,"finding":"CD94 forms disulfide-bonded heterodimers with NKG2A/B, NKG2C, and NKG2E glycoproteins; NKG2A/B contains two ITIM sequences in its cytoplasmic domain mediating inhibitory function, whereas other NKG2 partners lack ITIMs and may transmit positive signals.","method":"Biochemical co-immunoprecipitation, structural domain analysis","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical demonstration of heterodimer assembly with functional domain analysis, foundational paper","pmids":["8943374"],"is_preprint":false},{"year":1997,"finding":"NKG2A (43 kDa) is covalently associated with CD94 on the NK cell surface; surface expression of NKG2A requires association with CD94 (glycosylation patterns of mature NKG2A only found when associated with CD94); the CD94/NKG2A complex delivers an inhibitory signal via its two ITIMs.","method":"Co-immunoprecipitation, glycosylation analysis, functional blocking with anti-CD94 mAb","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution and functional validation in multiple NK clones","pmids":["9034158"],"is_preprint":false},{"year":1998,"finding":"HLA-E is the specific ligand for CD94/NKG2A, CD94/NKG2B, and CD94/NKG2C receptors; HLA-E tetramers bound to NK cells and transfectants expressing these receptors but not to KIR family receptors; surface HLA-E expression protected target cells from lysis by CD94/NKG2A+ NK clones.","method":"HLA-E tetramer binding assay, NK cell cytotoxicity assay, transfectant cell lines","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstituted soluble tetramers plus functional cytotoxicity assay, >1800 citations, independently replicated","pmids":["9486650"],"is_preprint":false},{"year":1998,"finding":"CD94/NKG2A specifically recognizes HLA-E; antibodies against HLA-E, CD94, or CD94/NKG2A restored NK-mediated lysis of HLA-E+ targets; surface stabilization of HLA-E by appropriate leader-sequence peptides was sufficient to confer protection via CD94/NKG2A.","method":"NK cytotoxicity assay with antibody blocking, peptide-pulsed target cells, transfectants","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — multiple blocking experiments in independent transfectant system, replicated findings","pmids":["9560253"],"is_preprint":false},{"year":1998,"finding":"NK cells recognize HLA-E molecules via the CD94/NKG2A heterodimer, resulting in inhibition of cytolysis; only HLA class I signal peptides containing Met at position 2 (of the HLA-E binding peptide) conferred resistance to NK-mediated lysis, whereas Thr at position 2 did not, establishing peptide-dependent recognition.","method":"NK cytotoxicity assay, synthetic peptide pulsing of target cells, anti-CD94 blocking","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional reconstitution with defined peptide variants, replicated across labs","pmids":["9480992"],"is_preprint":false},{"year":1998,"finding":"The activating CD94/NKG2C receptor associates with DAP12 (an ITAM-containing signaling adaptor); efficient surface expression of CD94/NKG2C requires DAP12; charged residues in the transmembrane domains of DAP12 and NKG2C are required for this interaction.","method":"Co-immunoprecipitation, transfection with transmembrane domain mutants, surface expression analysis","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis demonstrating transmembrane charge requirement","pmids":["9655483"],"is_preprint":false},{"year":1998,"finding":"The activating CD94-associated 39-kDa protein (Kp39) is the product of the NKG2-C gene; NKG2-C covalently associates with CD94 to form an activating receptor complex in a subset of NK cells lacking NKG2-A expression, and its engagement triggers cytolytic activity.","method":"Immunoprecipitation, peptide mapping, RT-PCR on NK clones, redirected killing assay, COS7 co-transfection","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including reconstitution in transfected cells","pmids":["9485212"],"is_preprint":false},{"year":1998,"finding":"Engagement of CD94/NKG2A by HLA-E induces tyrosine phosphorylation of the NKG2A subunit and recruitment of SHP-1 phosphatase; these biochemical events are the mechanistic basis for inhibitory signaling; reconstituted in heterologous RBL-2H3 transfectants.","method":"Western blot/phosphorylation assay, co-immunoprecipitation of SHP-1 with NKG2A, RBL transfectant reconstitution, serotonin release inhibition assay","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — mechanistic reconstitution in heterologous cells with HLA-E interaction confirmed","pmids":["9565368"],"is_preprint":false},{"year":1998,"finding":"CD94/NKG2A is involved in NK cell recognition of HLA-G1; CD94-specific mAbs reconstituted cytolytic activity against HLA-G1 transfectants comparably to anti-HLA class I mAbs, establishing CD94/NKG2A as the predominant inhibitory receptor for HLA-G.","method":"NK cytotoxicity assay, antibody blocking with anti-CD94 and anti-HLA mAbs, transfectant target cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple blocking experiments with defined transfectants, replicated by independent groups","pmids":["9190923","9233599"],"is_preprint":false},{"year":1998,"finding":"The primary structure of HLA-E-bound peptides influences CD94/NKG2-mediated recognition beyond their ability to stabilize surface HLA-E; the HLA-G-derived nonamer triggered cytotoxicity very efficiently through the activating CD94/NKG2C receptor, suggesting higher affinity interaction.","method":"NK clone cytotoxicity assays with panel of synthetic peptide-loaded HLA-E transfectants","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — systematic peptide panel in functional assay with defined receptor-expressing clones","pmids":["9754572"],"is_preprint":false},{"year":1999,"finding":"Soluble CD94/NKG2A has higher binding affinity for HLA-E than CD94/NKG2C; both receptors show fast association and dissociation kinetics; recognition of HLA-E by both receptors is peptide-dependent; binding affinity of the peptide-HLA-E complex directly correlates with the NK cell response.","method":"Surface plasmon resonance/binding kinetics with soluble recombinant receptors and HLA-E tetramers, functional NK assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — quantitative in vitro binding kinetics with recombinant proteins plus functional correlation","pmids":["10428963"],"is_preprint":false},{"year":1999,"finding":"CD94/NKG2A specifically recognizes HLA-E and not classical HLA class I molecules; this interaction is strictly dependent on peptide binding to HLA-E (peptide stabilizes surface expression AND must form a recognized complex); all class I leader sequence peptides tested were recognized but amino acid variations affected recognition.","method":"Soluble CD94/NKG2A direct binding assay, NK cell functional assays, HLA-E transfectants","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — soluble receptor binding plus functional validation, orthogonal methods","pmids":["9886400"],"is_preprint":false},{"year":1999,"finding":"Crystal structure of the extracellular domain of CD94 reveals a unique C-type lectin fold in which the second alpha helix is replaced by a loop and the calcium-binding site is nonfunctional; the CD94 dimer interface reveals a putative HLA-E binding region and suggests how NKG2 interacts with CD94.","method":"X-ray crystallography at 2.6 Å resolution","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 — crystal structure determination","pmids":["10023772"],"is_preprint":false},{"year":1999,"finding":"CD94/NKG2A inhibitory signaling blocks CD16-triggered Syk kinase activation and ERK activation by impairing tyrosine phosphorylation of the CD16 zeta subunit, Shc adaptor protein phosphorylation, and Shc/Grb-2 complex formation, thereby blocking the Ras-ERK pathway required for cytotoxicity.","method":"Western blot phosphorylation assays, kinase activity assays, receptor co-engagement experiments in human NK cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — detailed biochemical pathway dissection with multiple signaling intermediates","pmids":["10358164"],"is_preprint":false},{"year":2002,"finding":"A peptide derived from the signal sequence of heat shock protein 60 (hsp60) binds HLA-E intracellularly, upregulates HLA-E/hsp60 surface levels on stressed cells, and the resulting complex is NOT recognized by CD94/NKG2A inhibitory receptors, providing a mechanism for NK cells to detect stressed cells.","method":"Peptide binding assay, surface HLA-E flow cytometry, NK cytotoxicity assay with CD94/NKG2A+ clones","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods demonstrating peptide-dependent loss of inhibitory recognition","pmids":["12461076"],"is_preprint":false},{"year":2002,"finding":"Both NKG2A ITIMs are required for maximal CD94/NKG2A inhibitory signaling; the membrane-distal ITIM (Y8) is of primary importance; Y8F mutation alone largely abolished SHP-1 colocalization and inhibition of FcεRI-mediated serotonin release, while Y40F retained ~70% inhibitory function.","method":"Site-directed mutagenesis of ITIM tyrosines, transfection into RBL-2H3, phosphorylation assays, SHP-1 co-immunoprecipitation, confocal microscopy, serotonin release inhibition assay","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with reconstitution and multiple functional readouts","pmids":["12165520"],"is_preprint":false},{"year":2002,"finding":"CD94/NKG2A receptors continuously recycle between cell surface and intracellular endosomal compartments in an energy- and cytoskeleton-dependent process that is independent of ligand binding or functional ITIM signaling; this trafficking is distinct from that of the activating CD94/NKG2C receptor.","method":"Flow cytometry, confocal microscopy, biochemical fractionation, ITIM mutant transfection in RBL-2H3 cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple imaging and biochemical methods with functional mutants","pmids":["12444112"],"is_preprint":false},{"year":2003,"finding":"Full-length Hsp70 protein and the Hsp70 C-terminal domain bind specifically to CD94 on NK cells; CD94-specific antibody completely abrogated Hsp70 binding; binding is concentration-dependent and specific (competition with unlabeled Hsp70 but not unrelated protein); the 14-mer Hsp70 peptide TKD also binds CD94.","method":"Immunofluorescence binding studies, antibody blocking, competition assay with unlabeled proteins, dose-response binding","journal":"Biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding with blocking, but single lab study without structural validation","pmids":["12675520"],"is_preprint":false},{"year":2006,"finding":"CD94/NKG2A inhibitory signaling prevents NK cell activation by disrupting actin network organization at the immunological synapse (iNKIS) and excluding lipid rafts from the contact site; mechanistically, SHP-1 is recruited and activated, leading to dephosphorylation of Vav1 (a guanine nucleotide exchange factor) and ezrin-radixin-moesin proteins, blocking actin-dependent recruitment of activation receptor complexes.","method":"Confocal microscopy of actin and lipid raft dynamics, phosphorylation assays for Vav1 and ERM proteins, pharmacological inhibition of actin polymerization and cholesterol depletion","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal mechanistic methods defining pathway from receptor engagement to actin disruption","pmids":["16951318"],"is_preprint":false},{"year":2007,"finding":"Crystal structure of CD94-NKG2A heterodimer at 2.5 Å reveals asymmetric dimerization interface despite structural homology between subunits, providing structural basis for preferred heterodimeric (vs. homodimeric) assembly; the invariant CD94 chain plays a dominant role in interacting with HLA-E compared to the variable NKG2 chain.","method":"X-ray crystallography at 2.5 Å, structure-based mutagenesis of HLA-E and CD94-NKG2A","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with mutagenesis validation","pmids":["18083576"],"is_preprint":false},{"year":2008,"finding":"Crystal structure of CD94-NKG2A in complex with HLA-E bound to HLA-G leader sequence peptide shows CD94 subunit dominates the interaction with HLA-E while NKG2A is more peripheral; CD94 dominates peptide-mediated contacts; 'lock and key' binding mode with few conformational changes upon ligation.","method":"X-ray crystallography of ternary complex, mutagenesis at CD94-NKG2A-HLA-E interface","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — ternary complex crystal structure plus mutagenesis validation","pmids":["18332182"],"is_preprint":false},{"year":2008,"finding":"Crystal structure of NKG2A/CD94/HLA-E at 4.4 Å confirms CD94 contacts the C-terminal region of the peptide (most variable among class I leader sequences); residues 167-170 of NKG2A/C account for the ~6-fold higher affinity of inhibitory NKG2A/CD94 vs. activating NKG2C/CD94 through effects at the CD94-NKG2 heterodimer interface rather than direct HLA-E contact.","method":"X-ray crystallography, binding affinity measurement, evolutionary analysis","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mechanistic interpretation of affinity differences","pmids":["18448674"],"is_preprint":false},{"year":2008,"finding":"Subtle changes in peptide conformation within the HLA-E binding groove (without changes in HLA-E heavy chain conformation) explain differential recognition by CD94-NKG2 receptors; HLA-Cw*07 peptide (poorly recognized) and HLA-G*01 peptide (high-affinity ligand) differ in peptide conformation within the groove.","method":"X-ray crystallography of HLA-E with two different leader peptides at 2.5 Å resolution","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — comparative crystal structures providing mechanistic insight into peptide discrimination","pmids":["18339401"],"is_preprint":false},{"year":2011,"finding":"CD94 is essential for resistance to mousepox; ectromelia virus-infected cells expressing Qa-1(b) are specifically recognized by the activating receptor CD94-NKG2E, establishing the molecular mechanism of NK-mediated antiviral defense in this model.","method":"CD94-knockout mouse, viral challenge model, NK cell depletion, Qa-1(b) blocking","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with defined viral phenotype and molecular identification of ligand-receptor pair","pmids":["21439856"],"is_preprint":false},{"year":2021,"finding":"The CD94/NKG2A inhibitory receptor educates uterine NK cells required for optimal pregnancy outcomes; NKG2A genetic ablation caused suboptimal maternal vascular responses, perturbed placental gene expression, reduced fetal weight, and features resembling pre-eclampsia; the maternal HLA-B→HLA-E→NKG2A pathway drives NK education for healthy pregnancy.","method":"NKG2A knockout mouse, placental and fetal phenotyping, GWAS of pre-eclampsia cases, genetic epistasis","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple orthogonal phenotypic readouts and human GWAS validation","pmids":["33887202"],"is_preprint":false},{"year":2000,"finding":"CD69-triggered ERK activation and degranulation are negatively regulated by co-engagement of CD94/NKG2A; in RBL transfectants expressing both receptors, CD94/NKG2A suppressed CD69-mediated ERK activation and cell degranulation; in human NK cells, CD94/NKG2A inhibited CD69-induced cytotoxicity.","method":"RBL transfectant co-expression system, ERK phosphorylation assay, degranulation assay, NK cytotoxicity assay","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — mechanistic reconstitution in transfectants plus validation in primary NK cells","pmids":["10671222"],"is_preprint":false},{"year":2004,"finding":"CD94/NKG2A and CD94/NKG2C bind mostly shared but partly distinct sets of HLA-E residues at the top of the α1/α2 domain; two HLA-E mutations (D69A and H155A) selectively abrogated binding to CD94/NKG2A but not CD94/NKG2C, demonstrating partial epitope discrimination.","method":"Alanine scanning mutagenesis of HLA-E, binding assay with soluble CD94/NKG2A and CD94/NKG2C","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with direct binding measurements for both receptors","pmids":["14971033"],"is_preprint":false},{"year":2005,"finding":"CD94/NKG2C couples to DAP12 in T cells as well as NK cells; specific engagement of CD94/NKG2C on CD8+ T cell clones triggered cytotoxicity, cytokine production, IL-2Rα upregulation and proliferative responses via DAP12 co-precipitation with anti-CD94 antibody.","method":"Co-immunoprecipitation of DAP12 with CD94/NKG2C in T cell clones, functional assays (cytotoxicity, cytokine production, proliferation)","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — direct co-IP with multiple functional readouts in primary T cell clones","pmids":["15940674"],"is_preprint":false},{"year":2005,"finding":"CD94/NKG2A on NK cells inhibits NK killing of immature dendritic cells (iDC) in proportion to receptor surface density; iDC downregulate HLA-E expression, reducing inhibitory signaling and enabling lysis by CD94/NKG2A+KIR− NK cells; mature DC with higher HLA-E are protected.","method":"NK-DC co-culture cytotoxicity assay, flow cytometric phenotyping, HLA-E expression measurement","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional assay with defined receptor and ligand, single lab","pmids":["12778484"],"is_preprint":false},{"year":2023,"finding":"Among 16 common HLA class I signal peptide variants, only 6 ('functional SPs') efficiently generate epitopes enabling CD94/NKG2 engagement; HLA-B/-21M induces high HLA-E expression but confers the lowest receptor recognition and competes with other SPs, reducing overall CD94/NKG2A recognition of target cells.","method":"Systematic peptide binding assay, HLA-E surface expression measurement, CD94/NKG2A/NKG2C functional recognition assays, population genetics analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1 — systematic quantitative in vitro reconstitution with 16 SP variants and functional validation","pmids":["37264229"],"is_preprint":false},{"year":2024,"finding":"LAG-3 sustains TOX expression in exhausted CD8 T cells and regulates a LAG-3-dependent circuit that generates a CD94/NKG2+ subset of exhausted T cells with enhanced cytotoxicity mediated by recognition of the stress ligand Qa-1b; loss of LAG-3 disrupts this CD94/NKG2-Qa-1b axis.","method":"Genetic KO of PD-1 and/or LAG-3 in chronic infection model, transcriptomics, functional cytotoxicity assay, Qa-1b blocking","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with multiple functional readouts and human validation","pmids":["39121847"],"is_preprint":false}],"current_model":"CD94 (KLRD1) is an invariant C-type lectin-like type II transmembrane glycoprotein that forms obligate disulfide-bonded heterodimers with NKG2 family members (NKG2A/B forming inhibitory receptors via ITIMs, NKG2C/E/H forming activating receptors via DAP12); the heterodimeric CD94/NKG2 complexes recognize HLA-E (or murine Qa-1b) loaded with peptides derived from HLA class I signal sequences, with CD94 making dominant contacts to the HLA-E heavy chain and mediating most peptide discrimination, while NKG2 isoform identity determines whether recognition triggers inhibitory SHP-1 recruitment (NKG2A, disrupting actin/Vav1/ERM signaling to suppress NK activation) or activating DAP12-ITAM signaling (NKG2C/E) to promote cytotoxicity and cytokine production in NK cells and CD8+ T cells."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing that CD94 is an orphan C-type lectin receptor with a minimal cytoplasmic domain resolved its identity but immediately raised the question of how it signals — implying obligate partnership with other subunits.","evidence":"Molecular cloning, sequence analysis, and chromosomal mapping of CD94 from human NK cells","pmids":["7589107"],"confidence":"High","gaps":["Signaling partner(s) not yet identified","Ligand unknown","No functional data beyond sequence inference"]},{"year":1996,"claim":"Identification of CD94's disulfide-bonded heterodimerization with NKG2A/B/C/E resolved the signaling question by showing that different NKG2 partners contribute distinct cytoplasmic domains — ITIMs for inhibition (NKG2A/B) or potential activating motifs (NKG2C/E).","evidence":"Co-immunoprecipitation and domain analysis in NK cells","pmids":["8943374"],"confidence":"High","gaps":["Ligand still unidentified","Activating signaling adaptor not yet identified","Surface expression dependency not established"]},{"year":1997,"claim":"Demonstration that NKG2A requires CD94 for surface expression and proper glycosylation established CD94 as the obligate chaperone/partner, not merely a co-receptor.","evidence":"Co-immunoprecipitation with glycosylation analysis and anti-CD94 blocking in multiple NK clones","pmids":["9034158"],"confidence":"High","gaps":["Ligand still unknown","Downstream signaling cascade undefined"]},{"year":1998,"claim":"Identification of HLA-E as the specific ligand for CD94/NKG2 receptors, with peptide-dependent recognition and functional protection of targets from NK lysis, resolved the central ligand question and linked the receptor system to MHC class I surveillance.","evidence":"HLA-E tetramer binding, NK cytotoxicity assays with HLA-E transfectants, synthetic peptide pulsing, antibody blocking across multiple independent laboratories","pmids":["9486650","9560253","9480992"],"confidence":"High","gaps":["Structural basis of peptide discrimination unknown","Affinity differences between inhibitory and activating receptors not quantified"]},{"year":1998,"claim":"Discovery that activating CD94/NKG2C signals through DAP12 via transmembrane charge interactions, while inhibitory CD94/NKG2A signals through SHP-1 recruited to phosphorylated ITIMs, defined the bifurcating signaling logic of the receptor system.","evidence":"Co-IP of DAP12 with NKG2C, transmembrane mutagenesis, SHP-1 co-precipitation with phospho-NKG2A, reconstitution in RBL-2H3 cells","pmids":["9655483","9565368","9485212"],"confidence":"High","gaps":["Downstream signaling pathway beyond SHP-1 not mapped","Relative ITIM contributions unknown","Role in T cells not established"]},{"year":1999,"claim":"Quantitative binding studies and the first CD94 crystal structure established the biophysical framework: CD94/NKG2A binds HLA-E with higher affinity than CD94/NKG2C via fast kinetics, and CD94 adopts a modified C-type lectin fold lacking a functional calcium site.","evidence":"Surface plasmon resonance with recombinant receptors; X-ray crystallography of CD94 at 2.6 Å","pmids":["10428963","10023772"],"confidence":"High","gaps":["Heterodimer structure not yet solved","Structural basis for NKG2A vs NKG2C affinity difference unknown"]},{"year":1999,"claim":"Mapping of the downstream inhibitory signaling cascade showed that CD94/NKG2A blocks NK activation by interrupting CD16-triggered Syk/Shc/Grb2/ERK signaling at the level of zeta chain phosphorylation.","evidence":"Phosphorylation and kinase assays with receptor co-engagement in primary human NK cells","pmids":["10358164"],"confidence":"High","gaps":["Actin cytoskeleton involvement not yet addressed","Whether signaling inhibition extends to other activating receptors untested"]},{"year":2002,"claim":"Dissection of ITIM function showed the membrane-distal Y8 ITIM is the primary SHP-1 recruitment site, while the membrane-proximal Y40 is partially redundant, establishing the hierarchy of inhibitory signaling elements within NKG2A.","evidence":"Site-directed mutagenesis of ITIM tyrosines with SHP-1 co-IP, confocal colocalization, and serotonin release inhibition in RBL transfectants","pmids":["12165520"],"confidence":"High","gaps":["In vivo significance of individual ITIMs untested","Whether SHP-2 also participates not addressed"]},{"year":2002,"claim":"Discovery that hsp60-derived peptides bound to HLA-E are not recognized by CD94/NKG2A provided a mechanism for NK detection of stressed cells — loss of inhibitory recognition when the peptide repertoire shifts away from classical HLA leader sequences.","evidence":"Peptide binding, HLA-E surface measurement, and NK cytotoxicity with CD94/NKG2A+ clones","pmids":["12461076"],"confidence":"High","gaps":["In vivo relevance during infection or tumor stress not demonstrated","Whether activating NKG2C recognizes stress peptides not tested"]},{"year":2006,"claim":"Elucidation of the actin-level mechanism showed that CD94/NKG2A inhibition operates by SHP-1-mediated dephosphorylation of Vav1 and ERM proteins, disrupting actin polymerization and lipid raft recruitment at the immunological synapse — placing the inhibitory block upstream of all activating receptor signaling.","evidence":"Confocal imaging of actin and raft dynamics, Vav1/ERM phosphorylation assays, pharmacological perturbation in primary NK cells","pmids":["16951318"],"confidence":"High","gaps":["Whether this cytoskeletal mechanism applies to all inhibitory receptor families not determined","Quantitative threshold for inhibition unknown"]},{"year":2007,"claim":"Crystal structures of the CD94-NKG2A heterodimer and then the ternary CD94-NKG2A-HLA-E complex resolved how CD94 dominates HLA-E contact and peptide discrimination while NKG2 isoform identity tunes affinity allosterically through residues 167–170 at the heterodimer interface rather than direct ligand contact.","evidence":"X-ray crystallography at 2.5–4.4 Å resolution with structure-guided mutagenesis","pmids":["18083576","18332182","18448674"],"confidence":"High","gaps":["No structure of CD94/NKG2C-HLA-E complex for direct activating receptor comparison","Membrane-proximal signaling complex architecture unknown"]},{"year":2011,"claim":"Genetic ablation of CD94 in mice demonstrated in vivo essentiality: CD94-knockout mice succumbed to mousepox, with the activating CD94-NKG2E receptor recognizing Qa-1b on infected cells as the protective mechanism, establishing CD94 as indispensable for antiviral innate immunity.","evidence":"CD94-knockout mouse challenged with ectromelia virus, NK depletion, Qa-1b blocking","pmids":["21439856"],"confidence":"High","gaps":["Whether CD94/NKG2E recognizes virus-derived peptides in Qa-1b not determined","Human relevance of NKG2E-specific antiviral role unclear"]},{"year":2021,"claim":"NKG2A knockout revealed that the CD94/NKG2A inhibitory receptor educates uterine NK cells required for placental vascular remodeling; its loss causes pre-eclampsia-like features, establishing a non-redundant role for inhibitory CD94/NKG2A signaling in reproductive immunology.","evidence":"NKG2A-knockout mouse with placental/fetal phenotyping plus GWAS validation in human pre-eclampsia cohorts","pmids":["33887202"],"confidence":"High","gaps":["Mechanism linking NK education to vascular remodeling not fully defined","Whether CD94/NKG2C compensates partially in this context untested"]},{"year":2023,"claim":"Systematic analysis of all 16 common HLA class I signal peptide variants revealed that only 6 efficiently engage CD94/NKG2 receptors, and the HLA-B/-21M dimorphism paradoxically increases HLA-E expression while reducing receptor engagement, demonstrating that peptide quality — not just HLA-E quantity — governs NK cell education.","evidence":"Quantitative peptide binding, HLA-E expression, and CD94/NKG2A/NKG2C functional assays with 16 signal peptide variants","pmids":["37264229"],"confidence":"High","gaps":["How peptide competition shapes the overall HLA-E peptidome in vivo is not resolved","Impact on NK education threshold quantitatively undefined"]},{"year":2024,"claim":"Discovery that LAG-3 sustains a CD94/NKG2+ subset of exhausted CD8 T cells that kill via Qa-1b recognition expanded the receptor's role beyond NK cells into T cell exhaustion biology and checkpoint immunotherapy.","evidence":"Genetic knockout of LAG-3/PD-1 in chronic infection model with transcriptomics and Qa-1b blocking","pmids":["39121847"],"confidence":"High","gaps":["Whether therapeutic LAG-3 blockade disrupts CD94/NKG2 function in patients untested","Identity of Qa-1b-bound peptides driving this recognition unknown"]},{"year":null,"claim":"Key unresolved questions include the structural basis for activating CD94/NKG2C-HLA-E recognition, the in vivo peptidome presented by HLA-E to CD94/NKG2 receptors during infection and cancer, and how CD94/NKG2 receptor balance integrates with KIR and other checkpoint signals to set the NK cell activation threshold.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal structure of activating CD94/NKG2C-HLA-E complex","In vivo HLA-E peptidome during disease states not characterized","Quantitative integration with KIR and other checkpoint receptors not modeled"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[3,4,5,11]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[8,14,19]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,2,17]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[17]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,8,14,19,24]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,8,14,16,19]}],"complexes":["CD94/NKG2A","CD94/NKG2C","CD94/NKG2E"],"partners":["KLRC1","KLRC2","KLRC3","HLA-E","TYROBP","PTPN6"],"other_free_text":[]},"mechanistic_narrative":"CD94 (KLRD1) is an invariant C-type lectin-like type II transmembrane glycoprotein that forms obligate disulfide-bonded heterodimers with NKG2 family members to regulate NK cell and CD8+ T cell cytotoxicity through recognition of the non-classical MHC class I molecule HLA-E loaded with leader sequence-derived peptides [PMID:9486650, PMID:8943374, PMID:15940674]. Pairing with NKG2A/B generates an inhibitory receptor that recruits SHP-1 via NKG2A ITIMs, leading to dephosphorylation of Vav1 and ERM proteins and disruption of actin-dependent immunological synapse assembly, thereby blocking activating receptor signaling through the Ras-ERK pathway [PMID:9565368, PMID:16951318, PMID:10358164]. Pairing with NKG2C or NKG2E generates activating receptors that associate with the DAP12 ITAM-bearing adaptor to trigger cytotoxicity and cytokine production [PMID:9655483, PMID:9485212]. Crystal structures of the CD94-NKG2A-HLA-E ternary complex show that CD94 makes the dominant contacts with HLA-E and mediates most peptide discrimination, while residues 167–170 in the NKG2 subunit allosterically tune receptor affinity to enforce preferential inhibitory over activating signaling [PMID:18332182, PMID:18448674]."},"prefetch_data":{"uniprot":{"accession":"Q13241","full_name":"Natural killer cells antigen CD94","aliases":["KP43","Killer cell lectin-like receptor subfamily D member 1","NK cell receptor"],"length_aa":179,"mass_kda":20.5,"function":"Immune receptor involved in self-nonself discrimination. In complex with KLRC1 or KLRC2 on cytotoxic and regulatory lymphocyte subsets, recognizes non-classical major histocompatibility (MHC) class Ib molecule HLA-E loaded with self-peptides derived from the signal sequence of classical MHC class Ia and non-classical MHC class Ib molecules (PubMed:10023772, PubMed:18064301, PubMed:18083576, PubMed:37264229, PubMed:9486650, PubMed:9754572). Enables cytotoxic cells to monitor the expression of MHC class I molecules in healthy cells and to tolerate self (PubMed:12387742, PubMed:18064301, PubMed:9430220). Primarily functions as a ligand binding subunit as it lacks the capacity to signal KLRD1-KLRC1 acts as an immune inhibitory receptor. Key inhibitory receptor on natural killer (NK) cells that regulates their activation and effector functions (PubMed:30860984, PubMed:9430220, PubMed:9485206, PubMed:9486650). Dominantly counteracts T cell receptor signaling on a subset of memory/effector CD8-positive T cells as part of an antigen-driven response to avoid autoimmunity (PubMed:12387742). On intraepithelial CD8-positive gamma-delta regulatory T cells triggers TGFB1 secretion, which in turn limits the cytotoxic programming of intraepithelial CD8-positive alpha-beta T cells, distinguishing harmless from pathogenic antigens (PubMed:18064301). In HLA-E-rich tumor microenvironment, acts as an immune inhibitory checkpoint and may contribute to progressive loss of effector functions of NK cells and tumor-specific T cells, a state known as cell exhaustion (PubMed:30503213, PubMed:30860984). Upon HLA-E-peptide binding, transmits intracellular signals through KLRC1 immunoreceptor tyrosine-based inhibition motifs (ITIMs) by recruiting INPP5D/SHIP-1 and INPPL1/SHIP-2 tyrosine phosphatases to ITIMs, and ultimately opposing signals transmitted by activating receptors through dephosphorylation of proximal signaling molecules (PubMed:12165520, PubMed:9485206) KLRD1-KLRC2 acts as an immune activating receptor (PubMed:15940674, PubMed:9655483). On cytotoxic lymphocyte subsets recognizes HLA-E loaded with signal sequence-derived peptides from non-classical MHC class Ib HLA-G molecules, likely playing a role in the generation and effector functions of adaptive NK cells and in maternal-fetal tolerance during pregnancy (PubMed:30134159, PubMed:9754572). Regulates the effector functions of terminally differentiated cytotoxic lymphocyte subsets, and in particular may play a role in adaptive NK cell response to viral infection (PubMed:20952657, PubMed:21825173). Upon HLA-E-peptide binding, transmits intracellular signals via the adapter protein TYROBP/DAP12, triggering the phosphorylation of proximal signaling molecules and cell activation (PubMed:15940674, PubMed:9655483) (Microbial infection) Viruses like human cytomegalovirus have evolved an escape mechanism whereby virus-induced down-regulation of host MHC class I molecules is coupled to the binding of viral peptides to HLA-E, restoring HLA-E expression and inducing HLA-E-dependent NK cell immune tolerance to infected cells. Recognizes HLA-E in complex with human cytomegalovirus UL40-derived peptide (VMAPRTLIL) and inhibits NK cell cytotoxicity (Microbial infection) May recognize HLA-E in complex with HIV-1 gag/Capsid protein p24-derived peptide (AISPRTLNA) on infected cells and may inhibit NK cell cytotoxicity, a mechanism that allows HIV-1 to escape immune recognition (Microbial infection) Upon SARS-CoV-2 infection, may contribute to functional exhaustion of cytotoxic NK cells and CD8-positive T cells (PubMed:32859121). On NK cells, may recognize HLA-E in complex with SARS-CoV-2 S/Spike protein S1-derived peptide (LQPRTFLL) expressed on the surface of lung epithelial cells, inducing NK cell exhaustion and dampening antiviral immune surveillance (PubMed:32859121)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q13241/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KLRD1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KLRD1","total_profiled":1310},"omim":[{"mim_id":"611817","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY K, MEMBER 1; KLRK1","url":"https://www.omim.org/entry/611817"},{"mim_id":"606783","title":"C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER B; CLEC1B","url":"https://www.omim.org/entry/606783"},{"mim_id":"606782","title":"C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER A; CLEC1A","url":"https://www.omim.org/entry/606782"},{"mim_id":"604274","title":"KILLER CELL LECTIN-LIKE RECEPTOR A1, PSEUDOGENE; KLRA1P","url":"https://www.omim.org/entry/604274"},{"mim_id":"602894","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY D, MEMBER 1; KLRD1","url":"https://www.omim.org/entry/602894"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":16.2}],"url":"https://www.proteinatlas.org/search/KLRD1"},"hgnc":{"alias_symbol":[],"prev_symbol":["CD94"]},"alphafold":{"accession":"Q13241","domains":[{"cath_id":"3.10.100.10","chopping":"67-178","consensus_level":"high","plddt":96.6721,"start":67,"end":178},{"cath_id":"1.20.5","chopping":"2-38","consensus_level":"medium","plddt":80.9357,"start":2,"end":38}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13241","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13241-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13241-F1-predicted_aligned_error_v6.png","plddt_mean":87.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KLRD1","jax_strain_url":"https://www.jax.org/strain/search?query=KLRD1"},"sequence":{"accession":"Q13241","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13241.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13241/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13241"}},"corpus_meta":[{"pmid":"9486650","id":"PMC_9486650","title":"HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.","date":"1998","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9486650","citation_count":1811,"is_preprint":false},{"pmid":"9560253","id":"PMC_9560253","title":"HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9560253","citation_count":837,"is_preprint":false},{"pmid":"9480992","id":"PMC_9480992","title":"Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9480992","citation_count":567,"is_preprint":false},{"pmid":"9655483","id":"PMC_9655483","title":"Association of DAP12 with activating CD94/NKG2C NK cell receptors.","date":"1998","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9655483","citation_count":429,"is_preprint":false},{"pmid":"16384928","id":"PMC_16384928","title":"Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16384928","citation_count":355,"is_preprint":false},{"pmid":"9815261","id":"PMC_9815261","title":"Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).","date":"1998","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9815261","citation_count":355,"is_preprint":false},{"pmid":"8943374","id":"PMC_8943374","title":"Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.","date":"1996","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8943374","citation_count":352,"is_preprint":false},{"pmid":"9754572","id":"PMC_9754572","title":"HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9754572","citation_count":311,"is_preprint":false},{"pmid":"10428963","id":"PMC_10428963","title":"Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10428963","citation_count":298,"is_preprint":false},{"pmid":"10898498","id":"PMC_10898498","title":"HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10898498","citation_count":290,"is_preprint":false},{"pmid":"36706761","id":"PMC_36706761","title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance.","date":"2023","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/36706761","citation_count":258,"is_preprint":false},{"pmid":"8046333","id":"PMC_8046333","title":"Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.","date":"1994","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8046333","citation_count":223,"is_preprint":false},{"pmid":"9034158","id":"PMC_9034158","title":"NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9034158","citation_count":212,"is_preprint":false},{"pmid":"12461076","id":"PMC_12461076","title":"A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.","date":"2002","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12461076","citation_count":203,"is_preprint":false},{"pmid":"7589107","id":"PMC_7589107","title":"Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily.","date":"1995","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7589107","citation_count":201,"is_preprint":false},{"pmid":"19897577","id":"PMC_19897577","title":"CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19897577","citation_count":196,"is_preprint":false},{"pmid":"9448304","id":"PMC_9448304","title":"HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9448304","citation_count":194,"is_preprint":false},{"pmid":"12778484","id":"PMC_12778484","title":"The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.","date":"2003","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12778484","citation_count":193,"is_preprint":false},{"pmid":"18332182","id":"PMC_18332182","title":"CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.","date":"2008","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18332182","citation_count":190,"is_preprint":false},{"pmid":"10784586","id":"PMC_10784586","title":"Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease.","date":"2000","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/10784586","citation_count":185,"is_preprint":false},{"pmid":"18448674","id":"PMC_18448674","title":"Structural basis for NKG2A/CD94 recognition of HLA-E.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18448674","citation_count":176,"is_preprint":false},{"pmid":"12438449","id":"PMC_12438449","title":"IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.","date":"2002","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12438449","citation_count":175,"is_preprint":false},{"pmid":"10601355","id":"PMC_10601355","title":"Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.","date":"1999","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10601355","citation_count":166,"is_preprint":false},{"pmid":"9933082","id":"PMC_9933082","title":"Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes.","date":"1999","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9933082","citation_count":163,"is_preprint":false},{"pmid":"11812997","id":"PMC_11812997","title":"CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.","date":"2002","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11812997","citation_count":159,"is_preprint":false},{"pmid":"12675520","id":"PMC_12675520","title":"Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94.","date":"2003","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12675520","citation_count":151,"is_preprint":false},{"pmid":"22384114","id":"PMC_22384114","title":"Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22384114","citation_count":148,"is_preprint":false},{"pmid":"9209487","id":"PMC_9209487","title":"Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9209487","citation_count":138,"is_preprint":false},{"pmid":"9550399","id":"PMC_9550399","title":"CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9550399","citation_count":129,"is_preprint":false},{"pmid":"9886400","id":"PMC_9886400","title":"Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9886400","citation_count":126,"is_preprint":false},{"pmid":"9059892","id":"PMC_9059892","title":"Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules.","date":"1997","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/9059892","citation_count":120,"is_preprint":false},{"pmid":"17172651","id":"PMC_17172651","title":"The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.","date":"2006","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/17172651","citation_count":118,"is_preprint":false},{"pmid":"27853650","id":"PMC_27853650","title":"Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia.","date":"2016","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/27853650","citation_count":116,"is_preprint":false},{"pmid":"15805295","id":"PMC_15805295","title":"Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15805295","citation_count":115,"is_preprint":false},{"pmid":"10023772","id":"PMC_10023772","title":"Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors.","date":"1999","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10023772","citation_count":111,"is_preprint":false},{"pmid":"10328195","id":"PMC_10328195","title":"Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161.","date":"1999","source":"Archives of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/10328195","citation_count":110,"is_preprint":false},{"pmid":"9190923","id":"PMC_9190923","title":"The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9190923","citation_count":109,"is_preprint":false},{"pmid":"12387742","id":"PMC_12387742","title":"TCR specificity dictates CD94/NKG2A expression by human CTL.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12387742","citation_count":107,"is_preprint":false},{"pmid":"9565368","id":"PMC_9565368","title":"Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9565368","citation_count":101,"is_preprint":false},{"pmid":"9600963","id":"PMC_9600963","title":"Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9600963","citation_count":100,"is_preprint":false},{"pmid":"15258309","id":"PMC_15258309","title":"The role of CD94/NKG2 in innate and adaptive immunity.","date":"2004","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/15258309","citation_count":98,"is_preprint":false},{"pmid":"9233599","id":"PMC_9233599","title":"CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9233599","citation_count":95,"is_preprint":false},{"pmid":"24666761","id":"PMC_24666761","title":"The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.","date":"2014","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24666761","citation_count":93,"is_preprint":false},{"pmid":"21439856","id":"PMC_21439856","title":"CD94 is essential for NK cell-mediated resistance to a lethal viral disease.","date":"2011","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/21439856","citation_count":93,"is_preprint":false},{"pmid":"9464811","id":"PMC_9464811","title":"Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells.","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9464811","citation_count":93,"is_preprint":false},{"pmid":"9485212","id":"PMC_9485212","title":"The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.","date":"1998","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9485212","citation_count":93,"is_preprint":false},{"pmid":"7751628","id":"PMC_7751628","title":"Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen.","date":"1995","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7751628","citation_count":92,"is_preprint":false},{"pmid":"18339401","id":"PMC_18339401","title":"Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18339401","citation_count":88,"is_preprint":false},{"pmid":"15115287","id":"PMC_15115287","title":"Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells.","date":"2003","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/15115287","citation_count":87,"is_preprint":false},{"pmid":"19011664","id":"PMC_19011664","title":"HLA-E upregulation on IFN-gamma-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT.","date":"2008","source":"Bone marrow transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/19011664","citation_count":86,"is_preprint":false},{"pmid":"16951318","id":"PMC_16951318","title":"CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16951318","citation_count":85,"is_preprint":false},{"pmid":"18083576","id":"PMC_18083576","title":"The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.","date":"2007","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18083576","citation_count":81,"is_preprint":false},{"pmid":"9295021","id":"PMC_9295021","title":"HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9295021","citation_count":81,"is_preprint":false},{"pmid":"21800130","id":"PMC_21800130","title":"Clinical significance of the HLA-E and CD94/NKG2 interaction.","date":"2011","source":"Archivum immunologiae et therapiae experimentalis","url":"https://pubmed.ncbi.nlm.nih.gov/21800130","citation_count":80,"is_preprint":false},{"pmid":"14971033","id":"PMC_14971033","title":"The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.","date":"2004","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14971033","citation_count":79,"is_preprint":false},{"pmid":"31213473","id":"PMC_31213473","title":"Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses.","date":"2019","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/31213473","citation_count":77,"is_preprint":false},{"pmid":"39121847","id":"PMC_39121847","title":"LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity.","date":"2024","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/39121847","citation_count":76,"is_preprint":false},{"pmid":"10974028","id":"PMC_10974028","title":"Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.","date":"2000","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10974028","citation_count":74,"is_preprint":false},{"pmid":"33887202","id":"PMC_33887202","title":"The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and mice.","date":"2021","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/33887202","citation_count":73,"is_preprint":false},{"pmid":"15940674","id":"PMC_15940674","title":"The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.","date":"2005","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15940674","citation_count":73,"is_preprint":false},{"pmid":"26828202","id":"PMC_26828202","title":"A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.","date":"2016","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/26828202","citation_count":72,"is_preprint":false},{"pmid":"15607803","id":"PMC_15607803","title":"The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.","date":"2005","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15607803","citation_count":71,"is_preprint":false},{"pmid":"11751968","id":"PMC_11751968","title":"Conservation and variation in human and common chimpanzee CD94 and NKG2 genes.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11751968","citation_count":71,"is_preprint":false},{"pmid":"12518047","id":"PMC_12518047","title":"Urochordates and the origin of natural killer cells: identification of a CD94/NKR-P1-related receptor in blood cells of Botryllus.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12518047","citation_count":67,"is_preprint":false},{"pmid":"17521371","id":"PMC_17521371","title":"Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.","date":"2007","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17521371","citation_count":67,"is_preprint":false},{"pmid":"31409873","id":"PMC_31409873","title":"The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression.","date":"2019","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/31409873","citation_count":64,"is_preprint":false},{"pmid":"19124726","id":"PMC_19124726","title":"IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19124726","citation_count":63,"is_preprint":false},{"pmid":"9295048","id":"PMC_9295048","title":"Molecular characterization of a gene in the rat homologous to human CD94.","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9295048","citation_count":62,"is_preprint":false},{"pmid":"16424200","id":"PMC_16424200","title":"Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16424200","citation_count":60,"is_preprint":false},{"pmid":"10671222","id":"PMC_10671222","title":"CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10671222","citation_count":59,"is_preprint":false},{"pmid":"29898768","id":"PMC_29898768","title":"KLRD1-expressing natural killer cells predict influenza susceptibility.","date":"2018","source":"Genome medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29898768","citation_count":59,"is_preprint":false},{"pmid":"10358137","id":"PMC_10358137","title":"Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10358137","citation_count":58,"is_preprint":false},{"pmid":"12574337","id":"PMC_12574337","title":"Preferential survival of CD8 T and NK cells expressing high levels of CD94.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12574337","citation_count":57,"is_preprint":false},{"pmid":"12697440","id":"PMC_12697440","title":"Expression of CD94-NKG2A inhibitory receptor is restricted to a subset of CD8+ T cells.","date":"2003","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12697440","citation_count":55,"is_preprint":false},{"pmid":"9469418","id":"PMC_9469418","title":"Participation of the CD94 receptor complex in costimulation of human natural killer cells.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9469418","citation_count":55,"is_preprint":false},{"pmid":"15517612","id":"PMC_15517612","title":"Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.","date":"2004","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15517612","citation_count":54,"is_preprint":false},{"pmid":"16488482","id":"PMC_16488482","title":"Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.","date":"2006","source":"Journal of reproductive immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16488482","citation_count":54,"is_preprint":false},{"pmid":"23062183","id":"PMC_23062183","title":"Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway.","date":"2013","source":"Respirology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/23062183","citation_count":52,"is_preprint":false},{"pmid":"12165520","id":"PMC_12165520","title":"Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12165520","citation_count":52,"is_preprint":false},{"pmid":"20132973","id":"PMC_20132973","title":"CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.","date":"2010","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20132973","citation_count":51,"is_preprint":false},{"pmid":"8816383","id":"PMC_8816383","title":"Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses.","date":"1996","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8816383","citation_count":50,"is_preprint":false},{"pmid":"37264229","id":"PMC_37264229","title":"HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responses.","date":"2023","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37264229","citation_count":49,"is_preprint":false},{"pmid":"10201920","id":"PMC_10201920","title":"Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10201920","citation_count":49,"is_preprint":false},{"pmid":"11254682","id":"PMC_11254682","title":"Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11254682","citation_count":47,"is_preprint":false},{"pmid":"15746081","id":"PMC_15746081","title":"IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15746081","citation_count":45,"is_preprint":false},{"pmid":"11782245","id":"PMC_11782245","title":"The KIR and CD94/NKG2 families of molecules in the rhesus monkey.","date":"2001","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/11782245","citation_count":44,"is_preprint":false},{"pmid":"11513155","id":"PMC_11513155","title":"Ly49 and CD94/NKG2: developmentally regulated expression and evolution.","date":"2001","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/11513155","citation_count":42,"is_preprint":false},{"pmid":"21151939","id":"PMC_21151939","title":"Development and function of CD94-deficient natural killer cells.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21151939","citation_count":41,"is_preprint":false},{"pmid":"17706207","id":"PMC_17706207","title":"Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.","date":"2007","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/17706207","citation_count":39,"is_preprint":false},{"pmid":"15888249","id":"PMC_15888249","title":"HLA-E up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells.","date":"2005","source":"International journal of immunopathology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15888249","citation_count":39,"is_preprint":false},{"pmid":"21890659","id":"PMC_21890659","title":"Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94/NKG2A-positive NK cells.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21890659","citation_count":38,"is_preprint":false},{"pmid":"10358164","id":"PMC_10358164","title":"CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10358164","citation_count":37,"is_preprint":false},{"pmid":"16609008","id":"PMC_16609008","title":"Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells.","date":"2006","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/16609008","citation_count":36,"is_preprint":false},{"pmid":"24673109","id":"PMC_24673109","title":"Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.","date":"2014","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24673109","citation_count":36,"is_preprint":false},{"pmid":"12444112","id":"PMC_12444112","title":"NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12444112","citation_count":34,"is_preprint":false},{"pmid":"12653481","id":"PMC_12653481","title":"Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.","date":"2002","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/12653481","citation_count":34,"is_preprint":false},{"pmid":"9472066","id":"PMC_9472066","title":"Structure of the human CD94 C-type lectin gene.","date":"1998","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/9472066","citation_count":33,"is_preprint":false},{"pmid":"15714583","id":"PMC_15714583","title":"The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.","date":"2005","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15714583","citation_count":33,"is_preprint":false},{"pmid":"11994449","id":"PMC_11994449","title":"Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11994449","citation_count":33,"is_preprint":false},{"pmid":"11870631","id":"PMC_11870631","title":"NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2.","date":"2002","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11870631","citation_count":32,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48702,"output_tokens":7057,"usd":0.12598},"stage2":{"model":"claude-opus-4-6","input_tokens":10806,"output_tokens":3704,"usd":0.219945},"total_usd":0.345925,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"CD94 is a type II membrane glycoprotein encoded by a unique gene of the C-type lectin superfamily, located on human chromosome 12, and has an essentially absent cytoplasmic domain, implying association with other receptors is necessary for its function.\",\n      \"method\": \"Molecular cloning, sequence analysis, chromosomal mapping\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original molecular characterization with cloning, sequence, and chromosomal mapping\",\n      \"pmids\": [\"7589107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"CD94 forms disulfide-bonded heterodimers with NKG2A/B, NKG2C, and NKG2E glycoproteins; NKG2A/B contains two ITIM sequences in its cytoplasmic domain mediating inhibitory function, whereas other NKG2 partners lack ITIMs and may transmit positive signals.\",\n      \"method\": \"Biochemical co-immunoprecipitation, structural domain analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical demonstration of heterodimer assembly with functional domain analysis, foundational paper\",\n      \"pmids\": [\"8943374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"NKG2A (43 kDa) is covalently associated with CD94 on the NK cell surface; surface expression of NKG2A requires association with CD94 (glycosylation patterns of mature NKG2A only found when associated with CD94); the CD94/NKG2A complex delivers an inhibitory signal via its two ITIMs.\",\n      \"method\": \"Co-immunoprecipitation, glycosylation analysis, functional blocking with anti-CD94 mAb\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution and functional validation in multiple NK clones\",\n      \"pmids\": [\"9034158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"HLA-E is the specific ligand for CD94/NKG2A, CD94/NKG2B, and CD94/NKG2C receptors; HLA-E tetramers bound to NK cells and transfectants expressing these receptors but not to KIR family receptors; surface HLA-E expression protected target cells from lysis by CD94/NKG2A+ NK clones.\",\n      \"method\": \"HLA-E tetramer binding assay, NK cell cytotoxicity assay, transfectant cell lines\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted soluble tetramers plus functional cytotoxicity assay, >1800 citations, independently replicated\",\n      \"pmids\": [\"9486650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CD94/NKG2A specifically recognizes HLA-E; antibodies against HLA-E, CD94, or CD94/NKG2A restored NK-mediated lysis of HLA-E+ targets; surface stabilization of HLA-E by appropriate leader-sequence peptides was sufficient to confer protection via CD94/NKG2A.\",\n      \"method\": \"NK cytotoxicity assay with antibody blocking, peptide-pulsed target cells, transfectants\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple blocking experiments in independent transfectant system, replicated findings\",\n      \"pmids\": [\"9560253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"NK cells recognize HLA-E molecules via the CD94/NKG2A heterodimer, resulting in inhibition of cytolysis; only HLA class I signal peptides containing Met at position 2 (of the HLA-E binding peptide) conferred resistance to NK-mediated lysis, whereas Thr at position 2 did not, establishing peptide-dependent recognition.\",\n      \"method\": \"NK cytotoxicity assay, synthetic peptide pulsing of target cells, anti-CD94 blocking\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional reconstitution with defined peptide variants, replicated across labs\",\n      \"pmids\": [\"9480992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The activating CD94/NKG2C receptor associates with DAP12 (an ITAM-containing signaling adaptor); efficient surface expression of CD94/NKG2C requires DAP12; charged residues in the transmembrane domains of DAP12 and NKG2C are required for this interaction.\",\n      \"method\": \"Co-immunoprecipitation, transfection with transmembrane domain mutants, surface expression analysis\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis demonstrating transmembrane charge requirement\",\n      \"pmids\": [\"9655483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The activating CD94-associated 39-kDa protein (Kp39) is the product of the NKG2-C gene; NKG2-C covalently associates with CD94 to form an activating receptor complex in a subset of NK cells lacking NKG2-A expression, and its engagement triggers cytolytic activity.\",\n      \"method\": \"Immunoprecipitation, peptide mapping, RT-PCR on NK clones, redirected killing assay, COS7 co-transfection\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including reconstitution in transfected cells\",\n      \"pmids\": [\"9485212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Engagement of CD94/NKG2A by HLA-E induces tyrosine phosphorylation of the NKG2A subunit and recruitment of SHP-1 phosphatase; these biochemical events are the mechanistic basis for inhibitory signaling; reconstituted in heterologous RBL-2H3 transfectants.\",\n      \"method\": \"Western blot/phosphorylation assay, co-immunoprecipitation of SHP-1 with NKG2A, RBL transfectant reconstitution, serotonin release inhibition assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mechanistic reconstitution in heterologous cells with HLA-E interaction confirmed\",\n      \"pmids\": [\"9565368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CD94/NKG2A is involved in NK cell recognition of HLA-G1; CD94-specific mAbs reconstituted cytolytic activity against HLA-G1 transfectants comparably to anti-HLA class I mAbs, establishing CD94/NKG2A as the predominant inhibitory receptor for HLA-G.\",\n      \"method\": \"NK cytotoxicity assay, antibody blocking with anti-CD94 and anti-HLA mAbs, transfectant target cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple blocking experiments with defined transfectants, replicated by independent groups\",\n      \"pmids\": [\"9190923\", \"9233599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The primary structure of HLA-E-bound peptides influences CD94/NKG2-mediated recognition beyond their ability to stabilize surface HLA-E; the HLA-G-derived nonamer triggered cytotoxicity very efficiently through the activating CD94/NKG2C receptor, suggesting higher affinity interaction.\",\n      \"method\": \"NK clone cytotoxicity assays with panel of synthetic peptide-loaded HLA-E transfectants\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic peptide panel in functional assay with defined receptor-expressing clones\",\n      \"pmids\": [\"9754572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Soluble CD94/NKG2A has higher binding affinity for HLA-E than CD94/NKG2C; both receptors show fast association and dissociation kinetics; recognition of HLA-E by both receptors is peptide-dependent; binding affinity of the peptide-HLA-E complex directly correlates with the NK cell response.\",\n      \"method\": \"Surface plasmon resonance/binding kinetics with soluble recombinant receptors and HLA-E tetramers, functional NK assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative in vitro binding kinetics with recombinant proteins plus functional correlation\",\n      \"pmids\": [\"10428963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD94/NKG2A specifically recognizes HLA-E and not classical HLA class I molecules; this interaction is strictly dependent on peptide binding to HLA-E (peptide stabilizes surface expression AND must form a recognized complex); all class I leader sequence peptides tested were recognized but amino acid variations affected recognition.\",\n      \"method\": \"Soluble CD94/NKG2A direct binding assay, NK cell functional assays, HLA-E transfectants\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — soluble receptor binding plus functional validation, orthogonal methods\",\n      \"pmids\": [\"9886400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Crystal structure of the extracellular domain of CD94 reveals a unique C-type lectin fold in which the second alpha helix is replaced by a loop and the calcium-binding site is nonfunctional; the CD94 dimer interface reveals a putative HLA-E binding region and suggests how NKG2 interacts with CD94.\",\n      \"method\": \"X-ray crystallography at 2.6 Å resolution\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure determination\",\n      \"pmids\": [\"10023772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CD94/NKG2A inhibitory signaling blocks CD16-triggered Syk kinase activation and ERK activation by impairing tyrosine phosphorylation of the CD16 zeta subunit, Shc adaptor protein phosphorylation, and Shc/Grb-2 complex formation, thereby blocking the Ras-ERK pathway required for cytotoxicity.\",\n      \"method\": \"Western blot phosphorylation assays, kinase activity assays, receptor co-engagement experiments in human NK cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — detailed biochemical pathway dissection with multiple signaling intermediates\",\n      \"pmids\": [\"10358164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A peptide derived from the signal sequence of heat shock protein 60 (hsp60) binds HLA-E intracellularly, upregulates HLA-E/hsp60 surface levels on stressed cells, and the resulting complex is NOT recognized by CD94/NKG2A inhibitory receptors, providing a mechanism for NK cells to detect stressed cells.\",\n      \"method\": \"Peptide binding assay, surface HLA-E flow cytometry, NK cytotoxicity assay with CD94/NKG2A+ clones\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods demonstrating peptide-dependent loss of inhibitory recognition\",\n      \"pmids\": [\"12461076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Both NKG2A ITIMs are required for maximal CD94/NKG2A inhibitory signaling; the membrane-distal ITIM (Y8) is of primary importance; Y8F mutation alone largely abolished SHP-1 colocalization and inhibition of FcεRI-mediated serotonin release, while Y40F retained ~70% inhibitory function.\",\n      \"method\": \"Site-directed mutagenesis of ITIM tyrosines, transfection into RBL-2H3, phosphorylation assays, SHP-1 co-immunoprecipitation, confocal microscopy, serotonin release inhibition assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with reconstitution and multiple functional readouts\",\n      \"pmids\": [\"12165520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CD94/NKG2A receptors continuously recycle between cell surface and intracellular endosomal compartments in an energy- and cytoskeleton-dependent process that is independent of ligand binding or functional ITIM signaling; this trafficking is distinct from that of the activating CD94/NKG2C receptor.\",\n      \"method\": \"Flow cytometry, confocal microscopy, biochemical fractionation, ITIM mutant transfection in RBL-2H3 cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple imaging and biochemical methods with functional mutants\",\n      \"pmids\": [\"12444112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Full-length Hsp70 protein and the Hsp70 C-terminal domain bind specifically to CD94 on NK cells; CD94-specific antibody completely abrogated Hsp70 binding; binding is concentration-dependent and specific (competition with unlabeled Hsp70 but not unrelated protein); the 14-mer Hsp70 peptide TKD also binds CD94.\",\n      \"method\": \"Immunofluorescence binding studies, antibody blocking, competition assay with unlabeled proteins, dose-response binding\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding with blocking, but single lab study without structural validation\",\n      \"pmids\": [\"12675520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CD94/NKG2A inhibitory signaling prevents NK cell activation by disrupting actin network organization at the immunological synapse (iNKIS) and excluding lipid rafts from the contact site; mechanistically, SHP-1 is recruited and activated, leading to dephosphorylation of Vav1 (a guanine nucleotide exchange factor) and ezrin-radixin-moesin proteins, blocking actin-dependent recruitment of activation receptor complexes.\",\n      \"method\": \"Confocal microscopy of actin and lipid raft dynamics, phosphorylation assays for Vav1 and ERM proteins, pharmacological inhibition of actin polymerization and cholesterol depletion\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal mechanistic methods defining pathway from receptor engagement to actin disruption\",\n      \"pmids\": [\"16951318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structure of CD94-NKG2A heterodimer at 2.5 Å reveals asymmetric dimerization interface despite structural homology between subunits, providing structural basis for preferred heterodimeric (vs. homodimeric) assembly; the invariant CD94 chain plays a dominant role in interacting with HLA-E compared to the variable NKG2 chain.\",\n      \"method\": \"X-ray crystallography at 2.5 Å, structure-based mutagenesis of HLA-E and CD94-NKG2A\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with mutagenesis validation\",\n      \"pmids\": [\"18083576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure of CD94-NKG2A in complex with HLA-E bound to HLA-G leader sequence peptide shows CD94 subunit dominates the interaction with HLA-E while NKG2A is more peripheral; CD94 dominates peptide-mediated contacts; 'lock and key' binding mode with few conformational changes upon ligation.\",\n      \"method\": \"X-ray crystallography of ternary complex, mutagenesis at CD94-NKG2A-HLA-E interface\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — ternary complex crystal structure plus mutagenesis validation\",\n      \"pmids\": [\"18332182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure of NKG2A/CD94/HLA-E at 4.4 Å confirms CD94 contacts the C-terminal region of the peptide (most variable among class I leader sequences); residues 167-170 of NKG2A/C account for the ~6-fold higher affinity of inhibitory NKG2A/CD94 vs. activating NKG2C/CD94 through effects at the CD94-NKG2 heterodimer interface rather than direct HLA-E contact.\",\n      \"method\": \"X-ray crystallography, binding affinity measurement, evolutionary analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mechanistic interpretation of affinity differences\",\n      \"pmids\": [\"18448674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Subtle changes in peptide conformation within the HLA-E binding groove (without changes in HLA-E heavy chain conformation) explain differential recognition by CD94-NKG2 receptors; HLA-Cw*07 peptide (poorly recognized) and HLA-G*01 peptide (high-affinity ligand) differ in peptide conformation within the groove.\",\n      \"method\": \"X-ray crystallography of HLA-E with two different leader peptides at 2.5 Å resolution\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comparative crystal structures providing mechanistic insight into peptide discrimination\",\n      \"pmids\": [\"18339401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CD94 is essential for resistance to mousepox; ectromelia virus-infected cells expressing Qa-1(b) are specifically recognized by the activating receptor CD94-NKG2E, establishing the molecular mechanism of NK-mediated antiviral defense in this model.\",\n      \"method\": \"CD94-knockout mouse, viral challenge model, NK cell depletion, Qa-1(b) blocking\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with defined viral phenotype and molecular identification of ligand-receptor pair\",\n      \"pmids\": [\"21439856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The CD94/NKG2A inhibitory receptor educates uterine NK cells required for optimal pregnancy outcomes; NKG2A genetic ablation caused suboptimal maternal vascular responses, perturbed placental gene expression, reduced fetal weight, and features resembling pre-eclampsia; the maternal HLA-B→HLA-E→NKG2A pathway drives NK education for healthy pregnancy.\",\n      \"method\": \"NKG2A knockout mouse, placental and fetal phenotyping, GWAS of pre-eclampsia cases, genetic epistasis\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple orthogonal phenotypic readouts and human GWAS validation\",\n      \"pmids\": [\"33887202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD69-triggered ERK activation and degranulation are negatively regulated by co-engagement of CD94/NKG2A; in RBL transfectants expressing both receptors, CD94/NKG2A suppressed CD69-mediated ERK activation and cell degranulation; in human NK cells, CD94/NKG2A inhibited CD69-induced cytotoxicity.\",\n      \"method\": \"RBL transfectant co-expression system, ERK phosphorylation assay, degranulation assay, NK cytotoxicity assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mechanistic reconstitution in transfectants plus validation in primary NK cells\",\n      \"pmids\": [\"10671222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CD94/NKG2A and CD94/NKG2C bind mostly shared but partly distinct sets of HLA-E residues at the top of the α1/α2 domain; two HLA-E mutations (D69A and H155A) selectively abrogated binding to CD94/NKG2A but not CD94/NKG2C, demonstrating partial epitope discrimination.\",\n      \"method\": \"Alanine scanning mutagenesis of HLA-E, binding assay with soluble CD94/NKG2A and CD94/NKG2C\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with direct binding measurements for both receptors\",\n      \"pmids\": [\"14971033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CD94/NKG2C couples to DAP12 in T cells as well as NK cells; specific engagement of CD94/NKG2C on CD8+ T cell clones triggered cytotoxicity, cytokine production, IL-2Rα upregulation and proliferative responses via DAP12 co-precipitation with anti-CD94 antibody.\",\n      \"method\": \"Co-immunoprecipitation of DAP12 with CD94/NKG2C in T cell clones, functional assays (cytotoxicity, cytokine production, proliferation)\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct co-IP with multiple functional readouts in primary T cell clones\",\n      \"pmids\": [\"15940674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CD94/NKG2A on NK cells inhibits NK killing of immature dendritic cells (iDC) in proportion to receptor surface density; iDC downregulate HLA-E expression, reducing inhibitory signaling and enabling lysis by CD94/NKG2A+KIR− NK cells; mature DC with higher HLA-E are protected.\",\n      \"method\": \"NK-DC co-culture cytotoxicity assay, flow cytometric phenotyping, HLA-E expression measurement\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assay with defined receptor and ligand, single lab\",\n      \"pmids\": [\"12778484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Among 16 common HLA class I signal peptide variants, only 6 ('functional SPs') efficiently generate epitopes enabling CD94/NKG2 engagement; HLA-B/-21M induces high HLA-E expression but confers the lowest receptor recognition and competes with other SPs, reducing overall CD94/NKG2A recognition of target cells.\",\n      \"method\": \"Systematic peptide binding assay, HLA-E surface expression measurement, CD94/NKG2A/NKG2C functional recognition assays, population genetics analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic quantitative in vitro reconstitution with 16 SP variants and functional validation\",\n      \"pmids\": [\"37264229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LAG-3 sustains TOX expression in exhausted CD8 T cells and regulates a LAG-3-dependent circuit that generates a CD94/NKG2+ subset of exhausted T cells with enhanced cytotoxicity mediated by recognition of the stress ligand Qa-1b; loss of LAG-3 disrupts this CD94/NKG2-Qa-1b axis.\",\n      \"method\": \"Genetic KO of PD-1 and/or LAG-3 in chronic infection model, transcriptomics, functional cytotoxicity assay, Qa-1b blocking\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with multiple functional readouts and human validation\",\n      \"pmids\": [\"39121847\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD94 (KLRD1) is an invariant C-type lectin-like type II transmembrane glycoprotein that forms obligate disulfide-bonded heterodimers with NKG2 family members (NKG2A/B forming inhibitory receptors via ITIMs, NKG2C/E/H forming activating receptors via DAP12); the heterodimeric CD94/NKG2 complexes recognize HLA-E (or murine Qa-1b) loaded with peptides derived from HLA class I signal sequences, with CD94 making dominant contacts to the HLA-E heavy chain and mediating most peptide discrimination, while NKG2 isoform identity determines whether recognition triggers inhibitory SHP-1 recruitment (NKG2A, disrupting actin/Vav1/ERM signaling to suppress NK activation) or activating DAP12-ITAM signaling (NKG2C/E) to promote cytotoxicity and cytokine production in NK cells and CD8+ T cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CD94 (KLRD1) is an invariant C-type lectin-like type II transmembrane glycoprotein that forms obligate disulfide-bonded heterodimers with NKG2 family members to regulate NK cell and CD8+ T cell cytotoxicity through recognition of the non-classical MHC class I molecule HLA-E loaded with leader sequence-derived peptides [PMID:9486650, PMID:8943374, PMID:15940674]. Pairing with NKG2A/B generates an inhibitory receptor that recruits SHP-1 via NKG2A ITIMs, leading to dephosphorylation of Vav1 and ERM proteins and disruption of actin-dependent immunological synapse assembly, thereby blocking activating receptor signaling through the Ras-ERK pathway [PMID:9565368, PMID:16951318, PMID:10358164]. Pairing with NKG2C or NKG2E generates activating receptors that associate with the DAP12 ITAM-bearing adaptor to trigger cytotoxicity and cytokine production [PMID:9655483, PMID:9485212]. Crystal structures of the CD94-NKG2A-HLA-E ternary complex show that CD94 makes the dominant contacts with HLA-E and mediates most peptide discrimination, while residues 167–170 in the NKG2 subunit allosterically tune receptor affinity to enforce preferential inhibitory over activating signaling [PMID:18332182, PMID:18448674].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing that CD94 is an orphan C-type lectin receptor with a minimal cytoplasmic domain resolved its identity but immediately raised the question of how it signals — implying obligate partnership with other subunits.\",\n      \"evidence\": \"Molecular cloning, sequence analysis, and chromosomal mapping of CD94 from human NK cells\",\n      \"pmids\": [\"7589107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling partner(s) not yet identified\", \"Ligand unknown\", \"No functional data beyond sequence inference\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of CD94's disulfide-bonded heterodimerization with NKG2A/B/C/E resolved the signaling question by showing that different NKG2 partners contribute distinct cytoplasmic domains — ITIMs for inhibition (NKG2A/B) or potential activating motifs (NKG2C/E).\",\n      \"evidence\": \"Co-immunoprecipitation and domain analysis in NK cells\",\n      \"pmids\": [\"8943374\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ligand still unidentified\", \"Activating signaling adaptor not yet identified\", \"Surface expression dependency not established\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstration that NKG2A requires CD94 for surface expression and proper glycosylation established CD94 as the obligate chaperone/partner, not merely a co-receptor.\",\n      \"evidence\": \"Co-immunoprecipitation with glycosylation analysis and anti-CD94 blocking in multiple NK clones\",\n      \"pmids\": [\"9034158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Ligand still unknown\", \"Downstream signaling cascade undefined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of HLA-E as the specific ligand for CD94/NKG2 receptors, with peptide-dependent recognition and functional protection of targets from NK lysis, resolved the central ligand question and linked the receptor system to MHC class I surveillance.\",\n      \"evidence\": \"HLA-E tetramer binding, NK cytotoxicity assays with HLA-E transfectants, synthetic peptide pulsing, antibody blocking across multiple independent laboratories\",\n      \"pmids\": [\"9486650\", \"9560253\", \"9480992\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of peptide discrimination unknown\", \"Affinity differences between inhibitory and activating receptors not quantified\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Discovery that activating CD94/NKG2C signals through DAP12 via transmembrane charge interactions, while inhibitory CD94/NKG2A signals through SHP-1 recruited to phosphorylated ITIMs, defined the bifurcating signaling logic of the receptor system.\",\n      \"evidence\": \"Co-IP of DAP12 with NKG2C, transmembrane mutagenesis, SHP-1 co-precipitation with phospho-NKG2A, reconstitution in RBL-2H3 cells\",\n      \"pmids\": [\"9655483\", \"9565368\", \"9485212\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling pathway beyond SHP-1 not mapped\", \"Relative ITIM contributions unknown\", \"Role in T cells not established\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Quantitative binding studies and the first CD94 crystal structure established the biophysical framework: CD94/NKG2A binds HLA-E with higher affinity than CD94/NKG2C via fast kinetics, and CD94 adopts a modified C-type lectin fold lacking a functional calcium site.\",\n      \"evidence\": \"Surface plasmon resonance with recombinant receptors; X-ray crystallography of CD94 at 2.6 Å\",\n      \"pmids\": [\"10428963\", \"10023772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Heterodimer structure not yet solved\", \"Structural basis for NKG2A vs NKG2C affinity difference unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapping of the downstream inhibitory signaling cascade showed that CD94/NKG2A blocks NK activation by interrupting CD16-triggered Syk/Shc/Grb2/ERK signaling at the level of zeta chain phosphorylation.\",\n      \"evidence\": \"Phosphorylation and kinase assays with receptor co-engagement in primary human NK cells\",\n      \"pmids\": [\"10358164\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Actin cytoskeleton involvement not yet addressed\", \"Whether signaling inhibition extends to other activating receptors untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Dissection of ITIM function showed the membrane-distal Y8 ITIM is the primary SHP-1 recruitment site, while the membrane-proximal Y40 is partially redundant, establishing the hierarchy of inhibitory signaling elements within NKG2A.\",\n      \"evidence\": \"Site-directed mutagenesis of ITIM tyrosines with SHP-1 co-IP, confocal colocalization, and serotonin release inhibition in RBL transfectants\",\n      \"pmids\": [\"12165520\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of individual ITIMs untested\", \"Whether SHP-2 also participates not addressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that hsp60-derived peptides bound to HLA-E are not recognized by CD94/NKG2A provided a mechanism for NK detection of stressed cells — loss of inhibitory recognition when the peptide repertoire shifts away from classical HLA leader sequences.\",\n      \"evidence\": \"Peptide binding, HLA-E surface measurement, and NK cytotoxicity with CD94/NKG2A+ clones\",\n      \"pmids\": [\"12461076\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance during infection or tumor stress not demonstrated\", \"Whether activating NKG2C recognizes stress peptides not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Elucidation of the actin-level mechanism showed that CD94/NKG2A inhibition operates by SHP-1-mediated dephosphorylation of Vav1 and ERM proteins, disrupting actin polymerization and lipid raft recruitment at the immunological synapse — placing the inhibitory block upstream of all activating receptor signaling.\",\n      \"evidence\": \"Confocal imaging of actin and raft dynamics, Vav1/ERM phosphorylation assays, pharmacological perturbation in primary NK cells\",\n      \"pmids\": [\"16951318\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this cytoskeletal mechanism applies to all inhibitory receptor families not determined\", \"Quantitative threshold for inhibition unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Crystal structures of the CD94-NKG2A heterodimer and then the ternary CD94-NKG2A-HLA-E complex resolved how CD94 dominates HLA-E contact and peptide discrimination while NKG2 isoform identity tunes affinity allosterically through residues 167–170 at the heterodimer interface rather than direct ligand contact.\",\n      \"evidence\": \"X-ray crystallography at 2.5–4.4 Å resolution with structure-guided mutagenesis\",\n      \"pmids\": [\"18083576\", \"18332182\", \"18448674\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of CD94/NKG2C-HLA-E complex for direct activating receptor comparison\", \"Membrane-proximal signaling complex architecture unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Genetic ablation of CD94 in mice demonstrated in vivo essentiality: CD94-knockout mice succumbed to mousepox, with the activating CD94-NKG2E receptor recognizing Qa-1b on infected cells as the protective mechanism, establishing CD94 as indispensable for antiviral innate immunity.\",\n      \"evidence\": \"CD94-knockout mouse challenged with ectromelia virus, NK depletion, Qa-1b blocking\",\n      \"pmids\": [\"21439856\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD94/NKG2E recognizes virus-derived peptides in Qa-1b not determined\", \"Human relevance of NKG2E-specific antiviral role unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"NKG2A knockout revealed that the CD94/NKG2A inhibitory receptor educates uterine NK cells required for placental vascular remodeling; its loss causes pre-eclampsia-like features, establishing a non-redundant role for inhibitory CD94/NKG2A signaling in reproductive immunology.\",\n      \"evidence\": \"NKG2A-knockout mouse with placental/fetal phenotyping plus GWAS validation in human pre-eclampsia cohorts\",\n      \"pmids\": [\"33887202\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking NK education to vascular remodeling not fully defined\", \"Whether CD94/NKG2C compensates partially in this context untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Systematic analysis of all 16 common HLA class I signal peptide variants revealed that only 6 efficiently engage CD94/NKG2 receptors, and the HLA-B/-21M dimorphism paradoxically increases HLA-E expression while reducing receptor engagement, demonstrating that peptide quality — not just HLA-E quantity — governs NK cell education.\",\n      \"evidence\": \"Quantitative peptide binding, HLA-E expression, and CD94/NKG2A/NKG2C functional assays with 16 signal peptide variants\",\n      \"pmids\": [\"37264229\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How peptide competition shapes the overall HLA-E peptidome in vivo is not resolved\", \"Impact on NK education threshold quantitatively undefined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that LAG-3 sustains a CD94/NKG2+ subset of exhausted CD8 T cells that kill via Qa-1b recognition expanded the receptor's role beyond NK cells into T cell exhaustion biology and checkpoint immunotherapy.\",\n      \"evidence\": \"Genetic knockout of LAG-3/PD-1 in chronic infection model with transcriptomics and Qa-1b blocking\",\n      \"pmids\": [\"39121847\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether therapeutic LAG-3 blockade disrupts CD94/NKG2 function in patients untested\", \"Identity of Qa-1b-bound peptides driving this recognition unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for activating CD94/NKG2C-HLA-E recognition, the in vivo peptidome presented by HLA-E to CD94/NKG2 receptors during infection and cancer, and how CD94/NKG2 receptor balance integrates with KIR and other checkpoint signals to set the NK cell activation threshold.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of activating CD94/NKG2C-HLA-E complex\", \"In vivo HLA-E peptidome during disease states not characterized\", \"Quantitative integration with KIR and other checkpoint receptors not modeled\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [3, 4, 5, 11]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [8, 14, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 17]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 8, 14, 19, 24]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 8, 14, 16, 19]}\n    ],\n    \"complexes\": [\n      \"CD94/NKG2A\",\n      \"CD94/NKG2C\",\n      \"CD94/NKG2E\"\n    ],\n    \"partners\": [\n      \"KLRC1\",\n      \"KLRC2\",\n      \"KLRC3\",\n      \"HLA-E\",\n      \"TYROBP\",\n      \"PTPN6\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}